Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in AJR Am J Roentgenol Retrieve available abstracts of 69 articles: HTML format

Single Articles

March 2021
1. FLORES EJ, Narayan AK
   Beyond the AJR: "Using prediction-models to reduce persistent racial/ethnic disparities in draft 2020 USPSTF lung-cancer screening guidelines".
   AJR Am J Roentgenol. 2021 Mar 24. doi: 10.2214/AJR.21.25877.
   PubMed    
   
   
   
2. LEE GM, Stowell JT, Pope K, Carter BW, et al
   Lymphatic Pathways of the Thorax: Predictable Patterns of Spread.
   AJR Am J Roentgenol. 2021;216:649-658.
   PubMed     Abstract available
   
   
   January 2021
3. SERAI SD, Rapp JB, States LJ, Andronikou S, et al
   Pediatric Lung MRI: Currently Available and Emerging Techniques.
   AJR Am J Roentgenol. 2021 Jan 21:1-10. doi: 10.2214/AJR.20.23104.
   PubMed     Abstract available
   
   
   
4. DROSTEN R
   Editorial Comment: Practical Considerations in the Application of Recommendations for Suspected Infectious and Inflammatory Lung Abnormalities on Lung Cancer Screening CT.
   AJR Am J Roentgenol. 2021 Jan 20. doi: 10.2214/AJR.21.25447.
   PubMed    
   
   
   
5. JI Y, Shao CC, Cui Y, Cui K, et al
   The Diagnostic Value of FDG PET/CT and Thin-Slice High-Resolution Chest CT in Pulmonary Intravascular Metastasis.
   AJR Am J Roentgenol. 2021 Jan 6:1-7. doi: 10.2214/AJR.20.23017.
   PubMed     Abstract available
   
   
   December 2020
6. MENDOZA DP, Chintanapakdee W, Zhang EW, Gilman MD, et al
   Management and Outcomes of Suspected Infectious and Inflammatory Lung Abnormalities Identified on Lung Cancer Screening CT.
   AJR Am J Roentgenol. 2020 Dec 30. doi: 10.2214/AJR.20.25124.
   PubMed     Abstract available
   
   
   
7. PATEL BN, Langlotz CP
   Beyond the AJR: "Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model".
   AJR Am J Roentgenol. 2020 Dec 23. doi: 10.2214/AJR.20.25334.
   PubMed    
   
   
   
8. BOLEN MA
   Editorial Comment on "Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis".
   AJR Am J Roentgenol. 2020 Dec 2. doi: 10.2214/AJR.20.24243.
   PubMed    
   
   
   
9. AHUJA J, Shroff GS, Benveniste MF, Marom EM, et al
   In Situ Pulmonary Artery Thrombosis: Unrecognized Complication of Radiation Therapy.
   AJR Am J Roentgenol. 2020;215:1329-1334.
   PubMed     Abstract available
   
   
   November 2020
10. XUE Y, Chen D, Chen Y
    Reporting Accuracy in Prediction of Lymph Node Metastasis of Lung Adenocarcinoma With Radiomics.
    AJR Am J Roentgenol. 2020;215:W60.
    PubMed    
    
    
    October 2020
11. HATA A, Yanagawa M, Yoshida Y, Miyata T, et al
    Combination of Deep Learning-Based Denoising and Iterative Reconstruction for Ultra-Low-Dose CT of the Chest: Image Quality and Lung-RADS Evaluation.
    AJR Am J Roentgenol. 2020 Oct 14:1-8. doi: 10.2214/AJR.19.22680.
    PubMed     Abstract available
    
    
    
12. LITTLE BP, Junn JC, Zheng KS, Sanchez FW, et al
    Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Imaging and Clinical Features of a Frequently Delayed Diagnosis.
    AJR Am J Roentgenol. 2020 Oct 6:1-9. doi: 10.2214/AJR.19.22628.
    PubMed     Abstract available
    
    
    September 2020
13. OHNO Y, Takeshi Y, Takenaka D, Koyama H, et al
    Comparison of Diagnostic Accuracy for TNM Stage Among Whole-Body MRI and Coregistered PET/MRI Using 1.5-T and 3-T MRI Systems and Integrated PET/CT for Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2020 Sep 22:1-8. doi: 10.2214/AJR.19.22565.
    PubMed     Abstract available
    
    
    August 2020
14. GRASPARIL AD 2ND, Gottumukkala RV, Greer MC, Gee MS, et al
    Whole-Body MRI Surveillance of Cancer Predisposition Syndromes: Current Best Practice Guidelines for Use, Performance, and Interpretation.
    AJR Am J Roentgenol. 2020 Aug 18:1-10. doi: 10.2214/AJR.19.22399.
    PubMed     Abstract available
    
    
    July 2020
15. MENDOZA DP, Heeger A, Mino-Kenudson M, Lanuti M, et al
    Clinicopathologic and Longitudinal Imaging Features of Lung Cancer Associated with Cystic Airspaces: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2020 Jul 29. doi: 10.2214/AJR.20.23835.
    PubMed     Abstract available
    
    
    
16. MORTANI BARBOSA EJ JR, Yang R, Hershman M
    Real World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    AJR Am J Roentgenol. 2020 Jul 15. doi: 10.2214/AJR.20.23637.
    PubMed     Abstract available
    
    
    June 2020
17. LI Q, Li X, Li XY, Huo JW, et al
    Spectral CT in Lung Cancer: Usefulness of Iodine Concentration for Evaluation of Tumor Angiogenesis and Prognosis.
    AJR Am J Roentgenol. 2020 Jun 22:1-8. doi: 10.2214/AJR.19.22688.
    PubMed     Abstract available
    
    
    
18. BANKS KP, Peacock JG, Gusman M, Clemenshaw MN, et al
    It's About Quality, Not Quantity: Qualitative FDG PET/CT Criteria for Therapy Response Assessment in Clinical Practice.
    AJR Am J Roentgenol. 2020 Jun 17:1-12. doi: 10.2214/AJR.19.22642.
    PubMed     Abstract available
    
    
    April 2020
19. TAU N, Stundzia A, Yasufuku K, Hussey D, et al
    Convolutional Neural Networks in Predicting Nodal and Distant Metastatic Potential of Newly Diagnosed Non-Small Cell Lung Cancer on FDG PET Images.
    AJR Am J Roentgenol. 2020 Apr 29:1-6. doi: 10.2214/AJR.19.22346.
    PubMed     Abstract available
    
    
    
20. CHU ZG, Li WJ, Fu BJ, Lv FJ, et al
    CT Characteristics for Predicting Invasiveness in Pulmonary Pure Ground-Glass Nodules.
    AJR Am J Roentgenol. 2020 Apr 29:1-8. doi: 10.2214/AJR.19.22381.
    PubMed     Abstract available
    
    
    
21. SORENSEN L, Nielsen M, Petersen J, Pedersen JH, et al
    Chronic Obstructive Pulmonary Disease Quantification Using CT Texture Analysis and Densitometry: Results From the Danish Lung Cancer Screening Trial.
    AJR Am J Roentgenol. 2020 Apr 7:1-11. doi: 10.2214/AJR.19.22300.
    PubMed     Abstract available
    
    
    March 2020
22. MA Y, Byrne SC, Gange C Jr, Hunsaker AR, et al
    Radiologic-Pathologic Correlation for Nondiagnostic CT-Guided Lung Biopsies Performed for the Evaluation of Lung Cancer.
    AJR Am J Roentgenol. 2020 Mar 11:1-5. doi: 10.2214/AJR.19.22244.
    PubMed     Abstract available
    
    
    January 2020
23. ONISHI Y, Kusumoto M, Motoi N, Watanabe H, et al
    Ciliated Muconodular Papillary Tumor of the Lung: Thin-Section CT Findings of 16 Cases.
    AJR Am J Roentgenol. 2020 Jan 22:1-5. doi: 10.2214/AJR.19.21945.
    PubMed     Abstract available
    
    
    December 2019
24. MENDOZA DP, Lin JJ, Rooney MM, Chen T, et al
    Imaging Features and Metastatic Patterns of Advanced ALK-Rearranged Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2019 Dec 30:1-9. doi: 10.2214/AJR.19.21982.
    PubMed     Abstract available
    
    
    
25. SUH YJ, Park CM, Han K, Jeon SK, et al
    Utility of FDG PET/CT for Preoperative Staging of Non-Small Cell Lung Cancers Manifesting as Subsolid Nodules With a Solid Portion of 3 cm or Smaller.
    AJR Am J Roentgenol. 2019 Dec 17:1-9. doi: 10.2214/AJR.19.21811.
    PubMed     Abstract available
    
    
    November 2019
26. SHAO X, Niu R, Jiang Z, Shao X, et al
    Role of PET/CT in Management of Early Lung Adenocarcinoma.
    AJR Am J Roentgenol. 2019 Nov 12:1-9. doi: 10.2214/AJR.19.21585.
    PubMed     Abstract available
    
    
    October 2019
27. COLLETTI PM
    Earlier Diagnosis of Subcentimeter Lung Cancers Is Not Self-Evidently Beneficial: Personal Experience.
    AJR Am J Roentgenol. 2019;213:819-820.
    PubMed     Abstract available
    
    
    
28. REICH JM, Kim JS
    Earlier Diagnosis Not Self-Evidently Beneficial: Natural History of Subcentimeter Lung Cancers.
    AJR Am J Roentgenol. 2019;213:817-818.
    PubMed     Abstract available
    
    
    September 2019
29. OKAZAKI E, Seura H, Hasegawa Y, Okamura T, et al
    Prognostic Value of the Volumetric Parameters of Dual-Time-Point (18)F-FDG PET/CT in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy.
    AJR Am J Roentgenol. 2019 Sep 11:1-8. doi: 10.2214/AJR.19.21376.
    PubMed     Abstract available
    
    
    August 2019
30. KIM TH, Woo S, Yoon SH, Halpenny DF, et al
    CT Characteristics of Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangement: A Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2019 Aug 15:1-14. doi: 10.2214/AJR.19.21485.
    PubMed     Abstract available
    
    
    July 2019
31. CHEN L, Smith DA, Somarouthu B, Gupta A, et al
    A Radiologist's Guide to the Changing Treatment Paradigm of Advanced Non-Small Cell Lung Cancer: The ASCO 2018 Molecular Testing Guidelines and Targeted Therapies.
    AJR Am J Roentgenol. 2019 Jul 30:1-12. doi: 10.2214/AJR.19.21135.
    PubMed     Abstract available
    
    
    
32. KANDATHIL A, Iii RCS, Subramaniam RM
    Lung Cancer Recurrence: (18)F-FDG PET/CT in Clinical Practice.
    AJR Am J Roentgenol. 2019 Jul 30:1-9. doi: 10.2214/AJR.19.21227.
    PubMed     Abstract available
    
    
    June 2019
33. ZHAN Y, Peng X, Shan F, Feng M, et al
    Attenuation and Morphologic Characteristics Distinguishing a Ground-Glass Nodule Measuring 5-10 mm in Diameter as Invasive Lung Adenocarcinoma on Thin-Slice CT.
    AJR Am J Roentgenol. 2019 Jun 19:1-9. doi: 10.2214/AJR.18.21008.
    PubMed     Abstract available
    
    
    
34. LEE JH, Yoon SH, Kim YT, Kang CH, et al
    Sleeve Lobectomy for Non-Small Cell Lung Cancers: Predictive CT Features for Resectability and Outcome Analysis.
    AJR Am J Roentgenol. 2019 Jun 5:1-10. doi: 10.2214/AJR.19.21258.
    PubMed     Abstract available
    
    
    
35. LEMPEL JK, Raymond DP
    Intraoperative Percutaneous Microcoil Localization of Small Peripheral Pulmonary Nodules Using Cone-Beam CT in a Hybrid Operating Room.
    AJR Am J Roentgenol. 2019 Jun 5:1-4. doi: 10.2214/AJR.19.21175.
    PubMed     Abstract available
    
    
    May 2019
36. YANG Y, Li K, Sun D, Yu J, et al
    Invasive Pulmonary Adenocarcinomas Versus Preinvasive Lesions Appearing as Pure Ground-Glass Nodules: Differentiation Using Enhanced Dual-Source Dual-Energy CT.
    AJR Am J Roentgenol. 2019 May 13:1-9. doi: 10.2214/AJR.19.21245.
    PubMed     Abstract available
    
    
    
37. LI WJ, Chu ZG, Zhang Y, Li Q, et al
    Effect of Slab Thickness on the Detection of Pulmonary Nodules by Use of CT Maximum and Minimum Intensity Projection.
    AJR Am J Roentgenol. 2019 May 7:1-6. doi: 10.2214/AJR.19.21325.
    PubMed     Abstract available
    
    
    April 2019
38. OTANI T, Hosono M, Kanagaki M, Onishi Y, et al
    Evaluation and Optimization of a New PET Reconstruction Algorithm, Bayesian Penalized Likelihood Reconstruction, for Lung Cancer Assessment According to Lesion Size.
    AJR Am J Roentgenol. 2019 Apr 17:1-7. doi: 10.2214/AJR.18.20478.
    PubMed     Abstract available
    
    
    January 2019
39. WOO JH, Kim MY, Lee KS, Jeong DY, et al
    Resected Pure Small Cell Lung Carcinomas and Combined Small Cell Lung Carcinomas: Histopathology Features, Imaging Features, and Prognoses.
    AJR Am J Roentgenol. 2019 Jan 23:1-9. doi: 10.2214/AJR.18.20519.
    PubMed     Abstract available
    
    
    
40. LYONS GR, Winokur RS, Pua BB
    Pulmonary Cryoablation Zones: More Aggressive Ablation Is Warranted In Vivo.
    AJR Am J Roentgenol. 2019;212:195-200.
    PubMed     Abstract available
    
    
    December 2018
41. OHNO Y, Yui M, Aoyagi K, Kishida Y, et al
    Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
    AJR Am J Roentgenol. 2018 Dec 4:1-9. doi: 10.2214/AJR.18.20111.
    PubMed     Abstract available
    
    
    
42. GRUDEN JF, Green DB
    Reply to "Appropriate Timing for Follow-Up CT Imaging for Stable Lung CT Screening Reporting and Data System Category 3 Lesions Identified at Baseline Low-Dose CT".
    AJR Am J Roentgenol. 2018;211:W302.
    PubMed    
    
    
    
43. PANSE PM, Cummings KW, Gotway MB
    Appropriate Timing for Follow-Up CT Imaging for Stable Lung CT Screening Reporting and Data System Category 3 Lesions Identified at Baseline Low-Dose CT.
    AJR Am J Roentgenol. 2018;211:W301.
    PubMed    
    
    
    November 2018
44. OHNO Y, Yui M, Chen Y, Kishida Y, et al
    Gadolinium-Based Blood Volume Mapping From MRI With Ultrashort TE Versus CT and SPECT for Predicting Postoperative Lung Function in Patients With Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2018 Nov 13:1-10. doi: 10.2214/AJR.18.20095.
    PubMed     Abstract available
    
    
    September 2018
45. TU W, Verma R, Krishna S, McInnes MDF, et al
    Can Adrenal Adenomas Be Differentiated From Adrenal Metastases at Single-Phase Contrast-Enhanced CT?
    AJR Am J Roentgenol. 2018 Sep 12:1-7. doi: 10.2214/AJR.17.19276.
    PubMed     Abstract available
    
    
    July 2018
46. HASSANI C, Ronco A, Prosper AE, Dissanayake S, et al
    Forward-Projected Model-Based Iterative Reconstruction in Screening Low-Dose Chest CT: Comparison With Adaptive Iterative Dose Reduction 3D.
    AJR Am J Roentgenol. 2018 Jul 24:1-9. doi: 10.2214/AJR.17.19245.
    PubMed     Abstract available
    
    
    May 2018
47. KIM HK, Han J, Franks TJ, Lee KS, et al
    Colloid Adenocarcinoma of the Lung: CT and PET/CT Findings in Seven Patients.
    AJR Am J Roentgenol. 2018 May 24:W1-W8. doi: 10.2214/AJR.17.19273.
    PubMed     Abstract available
    
    
    April 2018
48. HANSBERRY DR, White MD, D'Angelo M, Prabhu AV, et al
    Lung Cancer Screening Guidelines: How Readable Are Internet-Based Patient Education Resources?
    AJR Am J Roentgenol. 2018 Apr 30:W1-W5. doi: 10.2214/AJR.17.19042.
    PubMed     Abstract available
    
    
    
49. KISHIDA Y, Seki S, Yoshikawa T, Itoh T, et al
    Performance Comparison Between (18)F-FDG PET/CT Plus Brain MRI and Conventional Staging Plus Brain MRI in Staging of Small Cell Lung Carcinoma.
    AJR Am J Roentgenol. 2018 Apr 18:1-8. doi: 10.2214/AJR.17.18935.
    PubMed     Abstract available
    
    
    
50. WESSELIUS LJ, DeLeon TT, Gotway MB
    A Sarcoidlike Reaction Mimicking Metastatic Malignancy in a Patient With Melanoma Treated With Pembrolizumab.
    AJR Am J Roentgenol. 2018;210:W183-W184.
    PubMed    
    
    
    March 2018
51. GARCIA-GARRIGOS E, Arenas-Jimenez JJ, Sanchez-Paya J
    Best Protocol for Combined Contrast-Enhanced Thoracic and Abdominal CT for Lung Cancer: A Single-Institution Randomized Crossover Clinical Trial.
    AJR Am J Roentgenol. 2018 Mar 23:1-9. doi: 10.2214/AJR.17.19185.
    PubMed     Abstract available
    
    
    
52. AVILA NA, Dwyer AJ, Moss J
    Reply to "Renal Lesions in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex Are Rarely Biologically Aggressive".
    AJR Am J Roentgenol. 2018;210:W132.
    PubMed    
    
    
    
53. TROUT AT, Towbin AJ, Franz DN
    Renal Lesions in Lymphangioleiomyomatosis and Tuberous Sclerosis Complex Are Rarely Biologically Aggressive.
    AJR Am J Roentgenol. 2018;210:W131.
    PubMed    
    
    
    January 2018
54. LO SB, Freedman MT, Gillis LB, White CS, et al
    JOURNAL CLUB: Computer-Aided Detection of Lung Nodules on CT With a Computerized Pulmonary Vessel Suppressed Function.
    AJR Am J Roentgenol. 2018 Jan 16:1-8. doi: 10.2214/AJR.17.18718.
    PubMed     Abstract available
    
    
    December 2017
55. LEE C
    Screening for Lung Cancer: Effective Recruitment Methods.
    AJR Am J Roentgenol. 2017 Dec 20:1-4. doi: 10.2214/AJR.17.18755.
    PubMed     Abstract available
    
    
    
56. CARTER BW, Lichtenberger JP 3rd, Wu CC, Munden RF, et al
    Screening for Lung Cancer: Lexicon for Communicating With Health Care Providers.
    AJR Am J Roentgenol. 2017 Dec 20:1-7. doi: 10.2214/AJR.17.18865.
    PubMed     Abstract available
    
    
    
57. CHUNG JH, Richards JC, Koelsch TL, MacMahon H, et al
    Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
    AJR Am J Roentgenol. 2017 Dec 12:1-11. doi: 10.2214/AJR.17.19003.
    PubMed     Abstract available
    
    
    
58. LI M, Narayan V, Gill RR, Jagannathan JP, et al
    Computer-Aided Diagnosis of Ground-Glass Opacity Nodules Using Open-Source Software for Quantifying Tumor Heterogeneity.
    AJR Am J Roentgenol. 2017;209:1216-1227.
    PubMed     Abstract available
    
    
    November 2017
59. GUICHET PL, Liu BY, Desai B, Surani Z, et al
    Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
    AJR Am J Roentgenol. 2017 Nov 22:1-8. doi: 10.2214/AJR.17.18853.
    PubMed     Abstract available
    
    
    
60. GREEN DB, Pua BB, Crawford CB, Abbey GN, et al
    Screening for Lung Cancer: Communicating With Patients.
    AJR Am J Roentgenol. 2017 Nov 22:1-6. doi: 10.2214/AJR.17.18836.
    PubMed     Abstract available
    
    
    
61. CHANG S, Hur J, Hong YJ, Lee HJ, et al
    Adverse Prognostic CT Findings for Patients With Advanced Lung Adenocarcinoma Receiving First-Line Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapy.
    AJR Am J Roentgenol. 2017 Nov 1:1-9. doi: 10.2214/AJR.17.18167.
    PubMed     Abstract available
    
    
    October 2017
62. MOULI SK, Kurilova I, Sofocleous CT, Lewandowski RJ, et al
    The Role of Percutaneous Image-Guided Thermal Ablation for the Treatment of Pulmonary Malignancies.
    AJR Am J Roentgenol. 2017;209:740-751.
    PubMed     Abstract available
    
    
    September 2017
63. OHNO Y, Fujisawa Y, Sugihara N, Kishida Y, et al
    Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non-Small Cell Lung Cancer.
    AJR Am J Roentgenol. 2017 Sep 20:W1-W10. doi: 10.2214/AJR.17.17959.
    PubMed     Abstract available
    
    
    
64. PINSKY PF, Gierada DS, Nath PH, Munden R, et al
    Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017 Sep 12:1-6. doi: 10.2214/AJR.17.18252.
    PubMed     Abstract available
    
    
    June 2017
65. WANG GX, Guo LQ, Gainor JF, Fintelmann FJ, et al
    Immune Checkpoint Inhibitors in Lung Cancer: Imaging Considerations.
    AJR Am J Roentgenol. 2017 Jun 28:1-9. doi: 10.2214/AJR.16.17770.
    PubMed     Abstract available
    
    
    
66. AHN SY, Park CM, Jeon YK, Kim H, et al
    Predictive CT Features of Visceral Pleural Invasion by T1-Sized Peripheral Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules.
    AJR Am J Roentgenol. 2017 Jun 22:1-6. doi: 10.2214/AJR.16.17280.
    PubMed     Abstract available
    
    
    
67. LIANG M, Yip R, Tang W, Xu D, et al
    Variation in Screening CT-Detected Nodule Volumetry as a Function of Size.
    AJR Am J Roentgenol. 2017 Jun 1:1-5. doi: 10.2214/AJR.16.17159.
    PubMed     Abstract available
    
    
    May 2017
68. YIP R, Henschke CI, Xu DM, Li K, et al
    Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017;208:1011-1021.
    PubMed     Abstract available
    
    
    March 2017
69. LEE C, Flynn MJ, Judy PF, Cody DD, et al
    Body Size-Specific Organ and Effective Doses of Chest CT Screening Examinations of the National Lung Screening Trial.
    AJR Am J Roentgenol. 2017 Mar 7:1-7. doi: 10.2214/AJR.16.16979.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: